Gossamer Bio, Inc.GOSSNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank78
3Y CAGR+306.4%
5Y CAGR+20.4%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+306.4%/yr
vs -91.1%/yr prior
5Y CAGR
+20.4%/yr
Recent acceleration
Acceleration
+397.5pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 25.71% |
| 2024 | 2.35% |
| 2023 | -20.84% |
| 2022 | 0.38% |
| 2021 | 7.77% |
| 2020 | 10.18% |
| 2019 | 159.40% |
| 2018 | 6104.60% |
| 2017 | 0.00% |
| 2016 | 0.00% |